MedPath

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

301

Active:4
Completed:49

Trial Phases

6 Phases

Early Phase 1:10
Phase 1:5
Phase 2:13
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (174 trials with phase data)• Click on a phase to view related trials

Not Applicable
120 (69.0%)
Phase 4
22 (12.6%)
Phase 2
13 (7.5%)
Early Phase 1
10 (5.7%)
Phase 1
5 (2.9%)
Phase 3
4 (2.3%)

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Recruiting
Conditions
Hepatitis B, Chronic (CHB)
Hepatitis B
Hepatitis B Virus (HBV)
Interventions
Drug: Peg IFN-α-2b
First Posted Date
2025-07-22
Last Posted Date
2025-07-22
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
1500
Registration Number
NCT07079150
Locations
🇨🇳

First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China

The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

Not yet recruiting
Conditions
HCV Infection
HCV Elimination
First Posted Date
2025-04-30
Last Posted Date
2025-04-30
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
200000
Registration Number
NCT06952036

Hypotension Prediction Index and Intraoperative Hypotension Incidence

Not Applicable
Not yet recruiting
Conditions
Intraoperative Hypotension
First Posted Date
2025-04-04
Last Posted Date
2025-04-04
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
100
Registration Number
NCT06909786
Locations
🇨🇳

the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy

Not Applicable
Not yet recruiting
Conditions
ST-segment Elevation Myocardial Infarction (STEMI)
Interventions
First Posted Date
2025-03-06
Last Posted Date
2025-03-06
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
2400
Registration Number
NCT06861374

The Value of Combined Detection of Different Blood Biomarkers in the Diagnosis and Treatments of Traumatic Brain Injury

Not yet recruiting
Conditions
Brain Injuries, Traumatic
Biomarkers
First Posted Date
2025-03-03
Last Posted Date
2025-03-03
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
80
Registration Number
NCT06854835
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 60
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.